Loading clinical trials...
Loading clinical trials...
Cognitive impairment is a major determinant of disability in schizophrenia. Aerobic exercise improves global cognition in schizophrenia, particularly working memory and attention/vigilance. Transcrani...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Kit Wa Chan
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT06894212 · Schizophrenia
NCT06223672 · Cognitive Decline, Cognitive Impairment
NCT06003036 · Schizophrenia, Schizoaffective Disorder
NCT06095297 · Long COVID, Brain Fog, and more
The University of Hong Kong
Hong Kong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions